Bachelot, A, and Binart, N. Reproductive role of prolactin. Reproduction. 2007, 133(2):361–369.CrossRefGoogle ScholarPubMed

Bernard, V, Young, J, Chanson, P, et al. New insights in prolactin: Pathological implications. Nat Rev Endocrinol. 2015, 11(5):265–275.CrossRefGoogle ScholarPubMed

Binart, N. Prolactin. In: Melmed, S, editor. The Pituitary. 2017; 129–161. London: Elsevier.CrossRefGoogle Scholar

Bernard, V, Young, J, and Binart, N. Prolactin – A pleiotropic factor in health and disease. Nat Rev Endocrinol. 2019, 15(6):356–365.CrossRefGoogle ScholarPubMed

Horseman, ND. Physiological actions and receptors. In: Tritos, NA, Klibanski, A, editors. Prolactin disorders from basic science to clinical management. 2019; 79–94. Springer Nature Switzerland AG: Humana Press.CrossRefGoogle Scholar

Newey, PJ, Gorvin, CM, and Thakker, RV. Mutant prolactin receptor and familial hyperprolactinemia. N Engl J Med. 2014, 370(10):977–978.Google ScholarPubMed

Kobayashi, T, Usui, H, Tanaka, H, et al. Variant prolactin receptor in agalactia and hyperprolactinemia. N Engl J Med. 2018, 379(23):2230–2236.CrossRefGoogle ScholarPubMed

Molitch, ME. Endocrinology in pregnancy: Management of the pregnant patient with a prolactinoma. Eur J Endocrinol. 2015, 172(5):R205–13.CrossRefGoogle ScholarPubMed

Kaiser, UB. Hyperprolactinemia and infertility: New insights. J Clin Invest. 2012, 122(10):3467–3468.Google Scholar

Sonigo, C, Bouilly, J, Carre, N, et al. Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. J Clin Invest. 2012, 122(10):3791–3795.Google Scholar

Demura, R, Ono, M, Demura, H, et al. Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17 beta-estradiol in the human ovary. J Clin Endocrinol Metab. 1982, 54(6):1246–1250.Google Scholar

Dorrington, JH, and Gore-Langton, RE. Antigonadal action of prolactin: Further studies on the mechanism of inhibition of follicle-stimulating hormone-induced aromatase activity in rat granulosa cell cultures. Endocrinology. 1982, 110(5):1701–1707.CrossRefGoogle ScholarPubMed

McNatty, KP. Relationship between plasma prolactin and the endocrine microenvironment of the developing human antral follicle. Fertil Steril. 1979, 32(4):433–438.CrossRefGoogle ScholarPubMed

Seppala, M, Ranta, T, and Hirvonen, E. Hyperprolactinaemia and luteal insufficiency. Lancet. 1976, 1(7953):229–230.CrossRefGoogle ScholarPubMed

Maiter, D. Prolactinoma and pregnancy: From the wish of conception to lactation. Ann Endocrinol (Paris). 2016, 77(2):128–134.CrossRefGoogle ScholarPubMed

Chanson, P, and Maiter, D. Prolactinoma. In: Melmed, S, editor. The Pituitary. 4th ed. 2017; 467–514. London: Elsevier.Google Scholar

Chanson, P, and Maiter, D. The epidemiology, diagnosis and treatment of prolactinomas: The old and the new. Best Pract Res Clin Endocrinol Metab. 2019:101290.Google Scholar

Souter, I, Baltagi, LM, Toth, TL, et al. Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility. Acta Obstet Gynecol Scand. 2010, 94(3):1159–1162.Google Scholar

Maiter, D. Prolactinomas in men. In: Tritos, NA, Klibanski, A, editors. Prolactin Disorders from Basic Science to Clinical Management. 2019; 189–204. Springer Nature Switzerland AG: Humana Press.Google Scholar

Ambulkar, SS, Darves-Bornoz, AL, Fantus, RJ, et al. Prevalence of hyperprolactinemia and clinically apparent prolactinomas in men undergoing fertility evaluation. Urology. 2021.CrossRefGoogle Scholar

Ben-Jonathan, N, and Hnasko, R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001, 22(6):724–763.CrossRefGoogle ScholarPubMed

Schuff, KG, Hentges, ST, Kelly, MA, et al. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest. 2002, 110(7):973–981.Google Scholar

Freeman, ME, Kanyicska, B, Lerant, A, et al. Prolactin: Structure, function, and regulation of secretion. Physiol Rev. 2000;80(4):1523–1631.CrossRefGoogle ScholarPubMed

Boockfor, FR, Hoeffler, JP, and Frawley, LS. Estradiol induces a shift in cultured cells that release prolactin or growth hormone. Am J Physiol. 1986, 250(1 Pt 1):E103–105.Google ScholarPubMed

Ben-Jonathan, N, LaPensee, CR, and LaPensee, EW. What can we learn from rodents about prolactin in humans? Endocr Rev. 2008, 29(1):1–41.CrossRefGoogle ScholarPubMed

Dinc, H, Esen, F, Demirci, A, et al. Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment. Acta Radiol. 1998, 39(1):64–69.Google ScholarPubMed

Gonzalez, JG, Elizondo, G, Saldivar, D, et al. Pituitary gland growth during normal pregnancy: An in vivo study using magnetic resonance imaging. Am J Med. 1988, 85(2):217–220.CrossRefGoogle Scholar

Knuth, UA, and Friesen, HG. Prolactin and pregnancy. In: Martini, L, James, VHT, editors. Current Topics in Experimental Endocrinology. 1983. 69–96. 4: Elsevier.Google Scholar

Biswas, S. Prolactin in amniotic fluid: Its correlation with maternal plasma prolactin. Clin Chim Acta. 1976, 73(2):363–367.Google Scholar

Rigg, LA, Lein, A, and Yen, SS. Pattern of increase in circulating prolactin levels during human gestation. Am J Obstet Gynecol. 1977, 129(4):454–456.Google Scholar

Grattan, DR, and Kokay, IC. Prolactin: A pleiotropic neuroendocrine hormone. J Neuroendocrinol. 2008, 20(6):752–763.CrossRefGoogle ScholarPubMed

Recent advances in medically assisted conception. Report of a WHO Scientific Group. 1992, 820:1-. Geneva: WHO; 1992.Google Scholar

Soto-Pedre, E, Newey, PJ, Bevan, JS, et al. The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: The Prolactin Epidemiology, Audit and Research Study (PROLEARS). Clin Endocrinol. 2017, 86(1):60–67.CrossRefGoogle ScholarPubMed

Huang, KE, Bonfiglio, TA, and Muechler, EK. Transient hyperprolactinemia in infertile women with luteal phase deficiency. Obstet Gynecol. 1991, 78(4):651–655.Google ScholarPubMed

Molitch, ME, and Reichlin, S. Hyperprolactinemic disorders. Dis Mon. 1982, 28(9):1–58.CrossRefGoogle ScholarPubMed

Touraine, P, Plu-Bureau, G, Beji, C, et al. Long-term follow-up of 246 hyperprolactinemic patients. Acta Obstet Gynecol Scand. 2001, 80(2):162–168.Google Scholar

Lee, DY, Oh, YK, Yoon, BK, et al. Prevalence of hyperprolactinemia in adolescents and young women with menstruation-related problems. Am J Obstet Gynecol. 2012, 206(3):213 e1–5.CrossRefGoogle Scholar

Binart, N, Young, J, and Chanson, P. Prolactin assays and regulation of secretion: animal and human data. In: Tritos, NA, Klibanski, A (Eds.) Prolactin Disorders from Basic Science to Clinical Management. Contemporary Endocrinology 2019; 55–78. Springer Nature Switzerland AG: Humana Press.Google Scholar

Fahie-Wilson, M, and Smith, TP. Determination of prolactin: The macroprolactin problem. Best Pract Res Clin Endocrinol Metab. 2013, 27(5):725–742.CrossRefGoogle ScholarPubMed

Kalsi, AK, Halder, A, Jain, M, et al. Prevalence and reproductive manifestations of macroprolactinemia. Endocrine. 2019, 63(2):332–340.Google Scholar

Karavitaki, N, Thanabalasingham, G, Shore, HC, et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf). 2006, 65(4):524–529.Google Scholar

Dohle, GR, Colpi, GM, Hargreave, TB, et al. EAU guidelines on male infertility. Eur Urol. 2005, 48(5):703–711.Google Scholar

Patel, DP, Chandrapal, JC, and Hotaling, JM. Hormone-Based Treatments in Subfertile Males. Curr Urol Rep. 2016, 17(8):56.Google Scholar

Iglesias, P, Bernal, C, Villabona, C, et al. Prolactinomas in men: A multicentre and retrospective analysis of treatment outcome. Clin Endocrinol (Oxf). 2012, 77(2):281–287.Google Scholar

Shimon, I, and Benbassat, C. Male prolactinomas presenting with normal testosterone levels. Pituitary. 2014;17(3):246–250.CrossRefGoogle ScholarPubMed

Colao, A, Vitale, G, Cappabianca, P, et al. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab. 2004, 89(4):1704–1711.Google Scholar

De Rosa, M, Ciccarelli, A, Zarrilli, S, et al. The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. Clin Endocrinol (Oxf). 2006, 64(3):307–313.Google Scholar

De Rosa, M, Zarrilli, S, Di Sarno, A, et al. Hyperprolactinemia in men: clinical and biochemical features and response to treatment. Endocrine. 2003, 20(1-2):75–82.Google Scholar

Pinzone, JJ, Katznelson, L, Danila, DC, et al. Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab. 2000, 85(9):3053–3057.Google ScholarPubMed

Molitch, M. Prolactin and pregnancy. In: Tritos, NA, Klibanski, A (Eds.), Prolactin Disorders from Basic Science to Clinical Management. Contemporary Endocrinology. 2019; 161–174. Springer Nature Switzerland AG: Humana Press.Google Scholar

Gillam, MP, Molitch, ME, Lombardi, G, et al. Advances in the treatment of prolactinomas. Endocr Rev. 2006, 27(5):485–534.CrossRefGoogle ScholarPubMed

Melmed, S, Casanueva, FF, Hoffman, AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011, 96(2):273–288.CrossRefGoogle ScholarPubMed

Glezer, A, and Bronstein, MD. Prolactinomas, cabergoline, and pregnancy. Endocrine. 2014, 47(1):64–69.CrossRefGoogle ScholarPubMed

Webster, J. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Saf. 1996, 14(4):228–238.CrossRefGoogle ScholarPubMed

Webster, J, Piscitelli, G, Polli, A, et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group (see comments). N Engl J Med. 1994, 331(14):904–909.CrossRefGoogle Scholar

Wang, AT, Mullan, RJ, Lane, MA, et al. Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev. 2012, 1:33.Google Scholar

Ono, M, Miki, N, Amano, K, et al. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab. 2010.Google Scholar

Verhelst, J, Abs, R, Maiter, D, et al. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab. 1999, 84(7):2518–2522.CrossRefGoogle ScholarPubMed

Laws, ER, Jr., Fode, NC, Randall, RV, et al. Pregnancy following transsphenoidal resection of prolactin-secreting pituitary tumors. J Neurosurg. 1983, 58(5):685–688.CrossRefGoogle ScholarPubMed

Buchfelder, M, Zhao, Y, and Schlaffer, SM. Surgery for prolactinomas to date. Neuroendocrinology. 2019.Google Scholar

Zamanipoor Najafabadi, AH, Zandbergen, IM, de Vries, F, et al. Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2020, 105(3).Google ScholarPubMed

Primeau, V, Raftopoulos, C, and Maiter, D. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. Eur J Endocrinol. 2012, 166(5):779–786.Google Scholar

McGarrigle, HH, Sarris, S, Little, V, et al. Induction of ovulation with clomiphene and human chorionic gonadotrophin in women with hyperprolactinaemic amenorrhoea. Br J Obstet Gynaecol. 1978, 85(9):692–697.Google Scholar

Lebbe, M, Hubinont, C, Bernard, P, et al. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. Clin Endocrinol (Oxf). 2010, 73(2):236–242.Google Scholar

Casanueva, FF, Molitch, ME, Schlechte, JA, et al. Guidelines of the pituitary society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006, 65(2):265–273.CrossRefGoogle ScholarPubMed

Ray, JG, Vermeulen, MJ, Bharatha, A, et al. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016, 316(9):952–961.CrossRefGoogle ScholarPubMed

Proenca, F, Guerreiro, C, Sa, G, et al Neuroimaging safety during pregnancy and lactation: a review. Neuroradiology. 2021.Google Scholar

Sant’ Anna, BG, Musolino, NRC, Gadelha, MR, et al. A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas. Pituitary. 2020, 23(2):120–128.Google Scholar

Lambert, K, Rees, K, Seed, PT, et al. Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes. Obstet Gynecol. 2017, 129(1):185–194.Google Scholar

Barraud, S, Guedra, L, Delemer, B, et al. Evolution of macroprolactinomas during pregnancy: A cohort study of 85 pregnancies. Clin Endocrinol (Oxf). 2020, 92(5):421–427.CrossRefGoogle ScholarPubMed

Huang, W, and Molitch, ME. Pituitary tumors in pregnancy. Endocrinol Metab Clin North Am. 2019, 48(3):569–581.Google Scholar

Araujo, B, Belo, S, and Carvalho, D. Pregnancy and tumor outcomes in women with prolactinoma. Exp Clin Endocrinol Diabetes. 2017, 125(10):642–648.Google Scholar

Galvao, A, Goncalves, D, Moreira, M, et al. Prolactinoma and pregnancy – A series of cases including pituitary apoplexy. J Obstet Gynaecol. 2017;37(3):284–287.Google Scholar

Karaca, Z, Yarman, S, Ozbas, I, et al. How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey. J Endocrinol Invest. 2018, 41(1):129–141.Google Scholar

O’Sullivan, SM, Farrant, MT, Ogilvie, CM, et al. An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists. Aust N Z J Obstet Gynaecol. 2020, 60(3):405–411.Google Scholar

Schlechte, JA. Clinical practice. Prolactinoma. N Engl J Med. 2003, 349(21):2035–2041.CrossRefGoogle ScholarPubMed

Divers, WA, Jr., and Yen, SS. Prolactin-producing microadenomas in pregnancy. Obstet Gynecol. 1983, 62(4):425–429.Google Scholar

Rastogi, A, Bhansali, A, Dutta, P, et al. A comparison between intensive and conventional cabergoline treatment of newly diagnosed patients with macroprolactinoma. Clin Endocrinol (Oxf). 2013, 79(3):409–415.Google Scholar

Graillon, T, Cuny, T, Castinetti, F, et al. Surgical indications for pituitary tumors during pregnancy: a literature review. Pituitary. 2020, 23(2):189–199.Google Scholar

Grand’Maison, S, Weber, F, Bedard, MJ, et al. Pituitary apoplexy in pregnancy: A case series and literature review. Obstet Med. 2015, 8(4):177–183.Google Scholar

Kuhn, E, Weinreich, AA, Biermasz, NR, et al. Apoplexy of microprolactinomas during pregnancy. Eur J Endocrinol. 2021.Google Scholar

Bronstein, MD. Prolactinomas and pregnancy. Pituitary. 2005, 8(1):31–38.Google Scholar

Molitch, ME. Prolactinoma in pregnancy. Best Pract Res Clin Endocrinol Metab. 2011, 25(6):885–896.CrossRefGoogle ScholarPubMed

Auriemma, RS, Perone, Y, Di Sarno, A, Grasso, LF, Guerra, E, Gasperi, M, et al. Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. J Clin Endocrinol Metab. 2013, 98(1):372–379.Google Scholar

Domingue, ME, Devuyst, F, Alexopoulou, O, et al. Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients. Clin Endocrinol (Oxf). 2014, 80(5):642–648.Google Scholar

Ikegami, H, Aono, T, Koizumi, K, et al. Relationship between the methods of treatment for prolactinomas and the puerperal lactation. Fertil Steril. 1987, 47(5):867–869.CrossRefGoogle ScholarPubMed

Bern, HA, and Nicoll, CS. The comparative endocrinology of prolactin. Recent Prog Horm Res. 1968, 24:681–720.Google ScholarPubMed

Biswas, S, and Rodeck, CH. Plasma prolactin levels during pregnancy. Br J Obstet Gynaecol. 1976, 83(9):683–687.Google Scholar

Karunakaran, S, Page, RC, and Wass, JA. The effect of the menopause on prolactin levels in patients with hyperprolactinaemia. Clin Endocrinol (Oxf). 2001, 54(3):295–300.Google Scholar

Huda, MS, Athauda, NB, Teh, MM, et al. Factors determining the remission of microprolactinomas after dopamine agonist withdrawal. Clin Endocrinol (Oxf). 2010, 72(4):507–511.CrossRefGoogle ScholarPubMed

Freemark, M. Placental hormones and the control of fetal growth. J Clin Endocrinol Metab. 2010, 95:2054–2057.Google Scholar

Monaghan, JM, Godber, IM, Lawson, N, et al. Longitudinal changes of insulin-like growth factors and their binding proteins troughout normal pregnancy. Ann Clin Biochem. 2004, 41:220–226.CrossRefGoogle Scholar

Asvold, BO, Eskild, A, Jenum, PA, et al. Maternal concentrations of insulin-like growth factor I and insulin-like growth factor binding protein 1 during pregnancy and birth weight of offspring. Am J Epidemiol. 2011, 174:129–135.Google Scholar

Dosouto, C, Calaf, J, Polo, A, et al. Growth hormone and reproduction: Lessons learned from animal models and clinical trials. Frontiers Endocrinol. 10.404. https://doi.org/10.3389/fendo.2019.00404.Google Scholar

Li, J, Chen, Q, Wang, J, et al. Does growth hormone supplementation improve oocyte competence and IVF outcomes in patients with poor embryonic development? A randomized controlled trial. BMC Pregnancy and Childbirth. 2020, 20:310. https://doi.org/10.1186/s12884–020-03004-9.Google Scholar

Cozzolino, M, Cecchino, GN, Trojano, DG, et al. Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: A systematic review and meta-analysis. Fertil Steril. 2020, 114:97–107.CrossRefGoogle ScholarPubMed

The ESHRE Guideline Group on Ovarian Stimulation, Bosch, M, et al. ESHRE guideline: Ovarian stimulation for IVF/ICSI. Human Reproduction Open 2020; p. 1–3. https://doi.org/10.1093/hropen/hoaa009.Google Scholar

de Boer, JA, Schoemaker, J, and van der Veen, EA. Impaired reproductive function in women treated for growth hormone deficiency during childhood. Clin Endocrinol. 1997, 46:681–689.Google Scholar

Giampetro, A, Milardi, D, Bianchi, A, et al. The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: Report of four cases and review of the literature. Fertil Steril. 2009, 91:930e7–930e11.Google Scholar

Tsilchorozidou, T, and Conway, GS. Uterus size and ovarian morphology in women with isolated growth hormone deficiency, hypogonadotrophic hypogonadism and hypopituitarism. Clin Endocrinol. 2004, 61:567–572.Google Scholar

Ipsa, E, Cruzat, VF, Kagize, JN, et al. Growth hormone and insulin-like growth factor action in reproductive tissues. Frontiers Endocrinol. 2019, 10:777. https://doi.org/10.3389/fendo.2019.00777.Google Scholar

Vila, G, and Luger, A. Growth hormone deficiency and pregnancy: Any role for substitution? Minerva Endocrinol. 2018, 43:451–457.Google Scholar

Vila, G, Akerblad, AC, Mattsson, A, et al. Pregnancy outcomes in women with growth hormone deficiency. Fertil Steril. 2015, 104:1210–1217.CrossRefGoogle ScholarPubMed

Luger, A, Broersen, LHA, Biermasz, NR, et al. Functioning and nonfunctioning pituitary adenomas in pregnancy. An ESE clinical practice guideline. Eur J Endocrinol. 2021,185:G1–G33Google Scholar

Casanueva, FF, Barkan, AL, Buchfelder, M, et al. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society statement. Pituitary. 2017, 20:489–498.Google Scholar

Grynberg, M, Salenave, S, Young, J, et al. Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab. 2010, 95:4518–4525.Google Scholar

Caron, P, Broussaud, S, Bertherat, J, et al. Acromegaly and pregnancy: A retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab. 2010, 95:4680–4687.Google Scholar

Katznelson, L, Laws, ER, Melmed, S, et al. Acromegaly: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014, 99:3933–3951.CrossRefGoogle ScholarPubMed

van der Lely, AJ, Gomez, R, Heissler, JF, et al. Pregnancy in acromegaly patients treated with pegvisomant. Endocrine. 2015, 49:769–773.Google Scholar

ACOG Committee Opinion. Guidelines for diagnostic imaging during pregnancy and lactation. Obstetrics Gynecol. 1017, 130:e210–e216.Google Scholar

Chanson, P, Vialon, M, and Caron, P. An update on clinical care for pregnant women with acromegaly. Exp Rev Endocrinol Metab. 2019, 14:85–96.Google Scholar

Abucham, J, Bronstein, MD, and Dias, ML. Acromegaly and pregnancy: A contemporary review. Eur J Endocrinol. 2017, 177:R1–R12.Google Scholar

Abs, R, Verhelst, J, Maiter, D, et al. Cabergoline in the treatment of acromegaly: A study in 64 patients. J Clin Endocrinol Metab. 1998, 83:374–378.Google Scholar

Graillon, T, Cuny, T, Castinetti, F, et al. Surgical indications for pituitary tumors during pregnancy: A literature review. Pituitary. 2020, 23:189–199.Google Scholar

Alexopoulou, O, Bex, M, Kamenicky, P, et al. Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: A study in 148 patients. Pituitary. 2014, 17:81–89.Google Scholar

Ciresi, A, Amato, MC, Pivonello, R, et al. The metabolic profile in active acromegaly is gender-specific. J Clin Endocrinol Meta. 2013, 98:E51–E59.CrossRefGoogle ScholarPubMed

Vialon, M, Grunenwald, S, Mouly, C, et al. Gestational diabetes and acromegaly: Single-centre experience in 14 pregnancies. Clin Endocrinol. 2019, 91:805–809.Google Scholar

Hod, M, Kapur, A, Sacks, DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynecol Obstet. 2015, 131(S3):S173–211.Google Scholar

Catalano, PM, Tyzbir, ED, and Roman, MN. Longitudinal changes in insulin release and insulin resistance in non obese pregnant women. Am J Ob Gynecol. 1991, 165: 1667–1672.Google Scholar

Di Cianni, G, Miccoli, R, Volpe, L, et al. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metabol Res Review. 2003, 19:259–270.Google Scholar

Hernandez, TL, Friedman, JE, Van Pelt, RE, et al. Patterns of glycemia in normal pregnancy: Should the current therapeutic targets be challenged? Diabetes Care. 2011, 34(7):1660–1668.CrossRefGoogle ScholarPubMed

Butte, NF. Carbohydrate and lipid metabolism in pregnancy: Normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000, 71(5):1256S–1261S.Google Scholar

Ryan, EA, and Enns, L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988, 67:341–347.Google Scholar

Zhou, J, Wu, NN, Yin, RL, et al. Activation of brown adipocytes by placentalgrowth factor. Biochem Biophys Res Commun. 2018, 504:470–477.Google Scholar

Powe, CE. Early pregnancy biochemical predictors of gestational diabetes mellitus. Curr Diab Rep. 2017, 17(2):12.Google Scholar

Simpson, S, Smith, L, and Bowe, J. Placental peptides regulating islet adaptation to pregnancy: Clinical potential in gestational diabetes mellitus. Curr Opin Pharmacol. 2018, 43:59–65.Google Scholar

Lorenzo-Almorós, A, et al. Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases. Cardiovasc Diabetol. 2019, 30;18(1):140.Google Scholar

McIntyre, HD, Chang, AM, Callaway, LK, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study cooperative research group: Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy. Diabetes Care. 2010, 33:356–360.Google Scholar

Catalano, PM, Hoegh, M, Minium, J, et al. Adiponectin in human pregnancy: Implications for regulation of glucose and lipid metabolism. Diabetologia. 2006, 49:1677–1685.Google Scholar

Buchanan, TA. Pancreatic B cell defects in gestational diabetes: Implications for the pathogenesis and prevention of type 2 diabetes. J. Clin. Endocrinol. Metab. 2001, 86:989–993.Google Scholar

Abouzeid, M, Versace, VL, Janus, ED, et al. Socio-cultural disparities in GDM burden differ by maternal age at first delivery. PLoS ONE. 2015, 10(2):e0117085.CrossRefGoogle ScholarPubMed

Schwartz, N, Nachum, Z, and Green, MS. The prevalence of gestational diabetes mellitus recurrence – Effect of ethnicity and parity: A metaanalysis. Am J Obstet Gynecol. 2015, 213(3):310–317.CrossRefGoogle ScholarPubMed

Palomba, S, de Wilde, MA, Falbo, A, et al. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015, 21(5):575–592.Google Scholar

HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008, 358:1991–2002.Google Scholar

International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Metzger, BE, Gabbe, SG, Persson, B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010, 33(3):676–682.Google Scholar

McIntyre, HD, Sacks, DA, Barbour, LA, et al. Issues with the diagnosis and classification of hyperglycemia in early pregnancy. Diabetes Care. 2016, 39(1):53–54.Google Scholar

Mitanchez, D, Yzydorczyk, C, Siddeek, B, et al. The offspring of the diabetic mother – Short- and long-term implications. Best Pract Res ClinObstet Gynaecol. 2015, 29: 256–269.Google Scholar

Rosenstein, MG, Cheng, YW, Snowden, JM, et al. The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes. Am J Obstet Gynecol. 2012, 206(4):309.e1–7.Google Scholar

Mastrogiannis, DS, Spiliopoulos, M, Mulla, W, et al. Insulin resistance: The possible link between gestational diabetes mellitus and hypertensive disorders of pregnancy. Curr Diab Rep. 2009, 9(4):296–302.Google Scholar

Khan, GH, Galazis, N, Docheva, N, et al. Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: A systematic review and biomarker database integration. Hum Reprod. 2015, 30:133–148.Google Scholar

Desoye, G, and Hauguel-de, MS. The human placenta in gestational diabetes mellitus: The insulin and cytokine network. Diabetes Care. 2007, 30(S2):S120–S126.Google Scholar

Kim, C, Newton, KM, and Knopp, RH. Gestational diabetes and the incidence of type 2 diabetes: A systematic review. Diabetes Care. 2002, 25:1862–1868.CrossRefGoogle ScholarPubMed

Bellamy, L, Casas, JP, Hingorani, AD, et al. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet. 2009, 373(9677):1773–1779.Google Scholar

Guo, J, Chen, JL, Whittemore, R, et al. Postpartum lifestyle interventions to prevent type 2 diabetes among women with history of gestational diabetes: A systematic review of randomized clinical trials. J Women’s Health. 2016, 25(1):38–49.Google Scholar

Golden, SH, Bennett, WL, Baptist-Roberts, K, et al. Antepartum glucose tolerance test results as predictors of type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: A systematic review. Gend. Med. 2009, 6(S1):109–122.Google Scholar

Shah, BR, Retnakaran, R, and Booth, GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care. 2008, 31:1668–1669.Google Scholar

Tobias, DK, Stuart, JJ, Li, S, et al. Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of US women. JAMA Intern Med. 2017, 177(12):1735–1742.Google Scholar

Retnakaran, R, and Shah, BR. Role of type 2 diabetes in determining retinal, renal, and cardiovascular outcomes in women with previous gestational diabetes mellitus. Diabetes Care. 2017, 40:101–108.Google Scholar

Clausen, TD, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: The role of intrauterine hyperglycemia. Diabetes Care. 2008, 31:340–346.Google Scholar

Lowe, WL Jr., et al. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA. 2018, 320:1005–1016.Google Scholar

Crowther, CA, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005, 352:2477–2486.Google Scholar

Landon, MB, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009, 361:1339–1348.Google Scholar

American Diabetes Association. 13. Management of diabetes in pregnancy: sStandards of medical care in diabetes – 2020. Diabetes Care. 2020, 43(Suppl 1):S183–S192.Google Scholar

Italian National Guidelines (Linee Guida Gravidanza Fisiologica). Sistema nazionale per le linee guida dell’Istituto Superiore di Sanità. Available at: www.snlg-iss.it/cms/files/Lg.Gravidanza.pdf.Google Scholar

Martis, R, Crowther, CA, Shepherd, E, et al. Treatments for women with gestational diabetes mellitus: An overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2018, 8:CD012327.Google Scholar

Brown, J, Grzeskowiak, L, Williamson, K, et al. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017, 11:CD012037.Google Scholar

Mecacci, F, Lisi, F, Vannuccini, S, et al. Different gestational diabetes phenotypes: Which insulin regimen fits better? Front. Endocrinol. 2021.Google Scholar

Rowan, JA, Hague, WM, Gao, W, et al. MiG trial investigators: Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008, 358: 2003–2015.Google Scholar

Balsells, M, Garca-Patterson, A, Sol, I, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: A systematic review and meta-analysis. BMJ. 2015, 350:h102.Google Scholar

Ijas, H., Vaarasmaki, M., Saarela, , et al. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: Growth and development of the children at the age of 18 months. BJOG. 2015, 122:994–1000.Google Scholar

Rowan, JA, Rush, EC, Plank, LD, et al. Metformin in gestational diabetes: The offspring follow-up (MiG TOFU): Body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res Care. 2018, 6:e000456.Google Scholar

van Weelden, W, Wekker, V, de Wit, L, et al. Long-term effects of oral antidiabetic drugs during pregnancy on offspring: A systematic review and meta-analysis of follow-up studies of RCTs. Diabetes Ther. 2018, 9:1811–1829.Google Scholar

Shepherd, E, Gomersall, JC, Tieu, J, et al. Combined diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. 2017, 11(11):CD010443.Google Scholar

Glazer, NL, Hendrickson, AF, Schellenbaum, GD, et al. Weight change and the risk of gestational diabetes in obese women. Epidemiology. 2004, 15(6):733–737.Google Scholar

Santamaria, A, Alibrandi, A, Di Benedetto, A ,et al. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: A secondary analysis from 3 RCTs. Am J Obstet Gynecol. 2018, 219(3):300.e1–300.Google Scholar

Dodd, JM et al. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: The GRoW randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019, 7:15–24.Google Scholar

Chiswick, C, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): A randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015, 3:778–786.Google Scholar

Zeng, XL, Zhang, YF, Tian, Q, et al. Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis. Medicine (Baltimore). 2016, 95(36):e4526.Google Scholar

Jones, DS, Podolsky, SH, and Greene, JA. The burden of disease and the changing task of medicine. The New England Journal of Medicine. 2012, 366:2333–2338.Google Scholar

(NCCDPHP) CsNCfCDPaHP. Chronic Diseases in America. In: (NCCDPHP) NCfCDPaHP, ed.: Center for Disease Control and Prevention, 2021.Google Scholar

Turnbaugh, PJ, Ley, RE, Mahowald, MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006, 444:1027–1031.Google Scholar

Hales, CM, Carroll, MD, Fryar, CD, et al. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018. NCHS data brief 2020:1-8.Google Scholar

Barnes, AS. The epidemic of obesity and diabetes: Trends and treatments. Texas Heart Institute Journal. 2011, 38:142–144.Google Scholar

Percent of Adults Who Are Overweight/Obese. In: Global Sherpa, 2011.Google Scholar

Eriksson, J, Forsén, T, Tuomilehto, J, et al. Size at birth, childhood growth and obesity in adult life. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 2001, 25:735–740.Google Scholar

Rolland-Cachera, MF, Deheeger, M, Maillot, M, et al. Early adiposity rebound: Causes and consequences for obesity in children and adults. International Journal of Obesity. 2005, 30 Suppl (4):S11–S17.Google Scholar

Hales, CM, Fryar, CD, Carroll, MD, et al. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007–2008 to 2015–2016. JAMA. 2018, 319:1723–1725.Google Scholar

Deputy, NP, Dub, B, and Sharma, AJ. Prevalence and trends in prepregnancy normal weight - 48 states, New York City, and District of Columbia, 2011–2015. MMWR Morbidity and Mortality Weekly Report. 2018, 66:1402–1407.Google Scholar

Neeland, IJ, Poirier, P, and Després, JP. Cardiovascular and metabolic heterogeneity of obesity: Clinical challenges and implications for management. Circulation. 2018, 137:1391–1406.Google Scholar

ACOG Practice Bulletin No 156: Obesity in pregnancy. Obstetrics and Gynecology. 2015, 126:e112–e126.Google Scholar

Villamor, E, and Cnattingius, S. Interpregnancy weight change and risk of adverse pregnancy outcomes: A population-based study. Lancet. 2006, 368:1164–1170.Google Scholar

Harmon, KA, Gerard, L, Jensen, DR, et al. Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: Metabolic determinants of fetal growth. Diabetes Care. 2011, 34:2198–2204.Google Scholar

Hedman, AM, Lundholm, C, Andolf, E, et al. Longitudinal plasma inflammatory proteome profiling during pregnancy in the Born into Life study. Scientific Reports. 2020, 10:17819.Google Scholar

Catalano, PM, and Shankar, K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ (Clinical Research Ed.). 2017, 356:j1.Google Scholar

Davis, NL SA, and Goodman, DA. Pregnancy-Related Deaths: Data from 14 U.S. Maternal Mortality Review Committees, 2008–2017. Centers for Disease Control and Prevention, US Department of Health and Human Services, 2019.Google Scholar

Ende, HB, Lozada, MJ, Chestnut, DH, et al. Risk factors for atonic postpartum hemorrhage: A systematic review and meta-analysis. Obstetrics and Gynecology. 2021, 137:305–323.Google Scholar

Cnattingius, S, Villamor, E, Johansson, S, et al. Maternal obesity and risk of preterm delivery. JAMA. 2013, 309:2362–2370.Google Scholar

Aune, D, Saugstad, OD, Henriksen, T, et al. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: A systematic review and meta-analysis. JAMA. 2014, 311:1536–1546.Google Scholar

Best, KE, Tennant, PW, Bell, R, et al. Impact of maternal body mass index on the antenatal detection of congenital anomalies. BJOG: An International Journal of Obstetrics and Gynaecology. 2012, 119:1503–1511.Google Scholar

Pucci, A, and Batterham, RL. Endocrinology of the gut and the regulation of body weight and metabolism. In: Feingold, KR, Anawalt, B, Boyce, A, Chrousos, G, de Herder, WW, Dungan, K, et al., eds. Endotext. South Dartmouth, MA: MDText.com, Inc. 2000.Google Scholar

Barsh, GS, and Schwartz, MW. Genetic approaches to studying energy balance: Perception and integration. Nature Reviews Genetics. 2002, 3:589–600.Google Scholar

Wallace, JM, Bhattacharya, S, and Horgan, GW. Weight change across the start of three consecutive pregnancies and the risk of maternal morbidity and SGA birth at the second and third pregnancy. PLoS ONE. 2017, 12:e0179589.Google Scholar

Peaceman, AM, Clifton, RG, Phelan, S, et al. Lifestyle interventions limit gestational weight gain in women with overweight or obesity: LIFE-Moms prospective meta-analysis. Obesity. 2018, 26:1396–1404.Google Scholar

Phelan, S, Clifton, RG, Haire-Joshu, D, et al. One-year postpartum anthropometric outcomes in mothers and children in the LIFE-Moms lifestyle intervention clinical trials. International Journal of Obesity. 2005, 2020(44):57–68.Google Scholar

Knowler, WC, Barrett-Connor, E, Fowler, SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002, 346:393–403.Google Scholar

Tchang, BG, Kumar, RB, and Aronne, LJ. Pharmacologic treatment of overweight and obesity in adults. In: Feingold, KR, Anawalt, B, Boyce, A, Chrousos, G, de Herder, WW, Dungan, K. et al., eds. Endotext. South Dartmouth, MA: MDText.com, Inc. 2000.Google Scholar

Courcoulas, AP, King, WC, Belle, SH, et al. Seven-year weight trajectories and health outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surgery. 2018, 153:427–434.Google Scholar

Benjamin, RH, Littlejohn, S, and Mitchell, LE. Bariatric surgery and birth defects: A systematic literature review. Paediatric and Perinatal Epidemiology. 2018, 32:533–544.Google Scholar

Neovius, M, Pasternak, B, Näslund, I, et al. Association of maternal gastric bypass surgery with offspring birth defects. JAMA. 2019, 322:1515–1517.Google Scholar

Elder, KA, and Wolfe, BM. Bariatric surgery: A review of procedures and outcomes. Gastroenterology. 2007, 132:2253–2271.Google Scholar

Kral, JG, Biron, S, Simard, S, et al. Large maternal weight loss from obesity surgery prevents transmission of obesity to children who were followed for 2 to 18 years. Pediatrics. 2006, 118:e1644–1649.Google Scholar

Smith, J, Cianflone, K, Biron, S, et al. Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. The Journal of Clinical Endocrinology and Metabolism. 2009, 94:4275–4283.Google Scholar

Willmer, M, Berglind, D, Tynelius, P, et al. Children’s weight status, body esteem, and self-concept after maternal gastric bypass surgery. Surgery for Obesity and Related Eiseases: Official Journal of the American Society for Bariatric Surgery. 2015, 11:927–932.Google Scholar

Barisione, M, Carlini, F, Gradaschi, R, et al. Body weight at developmental age in siblings born to mothers before and after surgically induced weight loss. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery. 2012, 8:387–391.Google Scholar

Willmer, M, Berglind, D, Sørensen, TI, et al. Surgically induced interpregnancy weight loss and prevalence of overweight and obesity in offspring. PLoS ONE. 2013, 8:e82247.Google Scholar

Guénard, F, Deshaies, Y, Cianflone, K, et al. Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proceedings of the National Academy of Sciences of the United States of America. 2013, 110:11439–11444.Google Scholar

Berglind, D, Müller, P, Willmer, M, et al. Differential methylation in inflammation and type 2 diabetes genes in siblings born before and after maternal bariatric surgery. Obesity. 2016, 24:250–261.Google Scholar

Svane, MS, Bojsen-Møller, KN, Martinussen, C, et al. Postprandial nutrient handling and gastrointestinal hormone secretion after Roux-en-Y gastric bypass vs sleeve gastrectomy. Gastroenterology. 2019, 156:1627–1641.e1.Google Scholar

Nohr, EA, Bech, BH, Davies, MJ, et al. Prepregnancy obesity and fetal death: A study within the Danish National Birth Cohort. Obstetrics and Gynecology. 2005, 106:250–259.Google Scholar

Ikedionwu, CA, Dongarwar, D, Yusuf, KK, et al. Pre-pregnancy maternal obesity, macrosomia, and risk of stillbirth: A population-based study. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2020, 252:1–6.Google Scholar

Marshall, NE, Guild, C, Cheng, YW, et al. Maternal superobesity and perinatal outcomes. American Journal of Obstetrics and Gynecology. 2012, 206(417):e1–6.Google Scholar

Beta, J, Khan, N, Khalil, A, et al. Maternal and neonatal complications of fetal macrosomia: Systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2019, 54:308–318.Google Scholar

Desai, M, and Ross, MG. Fetal programming of adipose tissue: Effects of intrauterine growth restriction and maternal obesity/high-fat diet. Seminars in Reproductive Medicine. 2011, 29:237–245.CrossRefGoogle ScholarPubMed

Kislal, S, Shook, LL, and Edlow, AG. Perinatal exposure to maternal obesity: Lasting cardiometabolic impact on offspring. Prenatal Diagnosis. 2020, 40:1109–11025.Google Scholar

Heslehurst, N, Vieira, R, Akhter, Z, et al. The association between maternal body mass index and child obesity: A systematic review and meta-analysis. PLoS Medicine. 2019, 16:e1002817.Google Scholar

Brumbaugh, DE, Tearse, P, Cree-Green, M, et al. Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes. The Journal of Pediatrics. 2013, 162:930–936.e1.Google Scholar

Cirulli, F, Musillo, C, and Berry, A. Maternal obesity as a risk factor for brain development and mental health in the offspring. Neuroscience. 2020, 447:122–135.Google Scholar

Basu, S, Haghiac, M, Surace, P, et al. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity. 2011, 19:476–482.Google Scholar

Breastfeeding and the use of human milk. Pediatrics. 2012;129:e827–841.Google Scholar

Marshall, NE, Lau, B, Purnell, JQ, et al. Impact of maternal obesity and breastfeeding intention on lactation intensity and duration. Maternal & Child Nutrition. 2019, 15:e12732.Google Scholar

Kugyelka, JG, Rasmussen, KM, and Frongillo, EA. Maternal obesity is negatively associated with breastfeeding success among Hispanic but not Black women. The Journal of Nutrition. 2004, 134:1746–1753.Google Scholar

Chapman, DJ, and Pérez-Escamilla, R. Maternal perception of the onset of lactation is a valid, public health indicator of lactogenesis stage II. The Journal of Nutrition. 2000, 130:2972–2980.Google Scholar

Amir, LH, and Donath, S. A systematic review of maternal obesity and breastfeeding intention, initiation and duration. BMC Pregnancy and Childbirth. 2007, 7:9.Google Scholar

Piercy, KL, and Troiano, RP. Physical activity guidelines for Americans from the US Department of Health and Human Services. Circulation Cardiovascular Quality and Outcomes. 2018, 11:e005263.Google Scholar

Agriculture USDo SU. Dietary Guidelines for Americans, 2020–2025. In: USDoHaH, ed. Vol. 9th Edition. 2020.Google Scholar

ACOG Committee opinion no. 548: Weight gain during pregnancy. Obstetrics and Gynecology. 2013, 121:210–212.Google Scholar

Voerman, E, Santos, S, Inskip, H, et al. Association of gestational weight gain with adverse maternal and infant outcomes. JAMA. 2019, 321:1702–1715.Google Scholar

Poston, L, Bell, R, Croker, H, et al. Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): A multicentre, randomised controlled trial. The Lancet Diabetes & Endocrinology. 2015, 3:767–77.Google Scholar

Luppino, FS, de Wit, LM, Bouvy, PF, et al. Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Archives of General Psychiatry. 2010, 67:220–229.Google Scholar

Chawanpaiboon, S, Vogel, JP, Moller, A-B, et al. Global, regional, and national estimates of levels of preterm birth in 2014: A systematic review and modelling analysis. The Lancet Global Health. 2019, 7(1):e37–e46.Google Scholar

UNICEF, WHO, World Bank Group and United Nations. United Nations Inter-agency Group for Child Mortality Estimation (UN IGME). Levels & Trends in Child Mortality: Report 2019, Estimates Developed by the United Nations Inter-Agency Group for Child Mortality Estimation. New York: 2019.Google Scholar

Blencowe, H, Cousens, S, Oestergaard, MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: A systematic analysis and implications. The Lancet. 2012, 379(9832):2162–2172.Google Scholar

Goldenberg, RL, Culhane, JF, Iams, JD, et al. Epidemiology and causes of preterm birth. The Lancet. 2008, 371(9606):75–84.Google Scholar

Mactier, H, Bates, SE, Johnston, T, et al. Perinatal management of extreme preterm birth before 27 weeks of gestation: A framework for practice. Archives of Disease in Childhood: Fetal and Neonatal Edition. 2020, 105(3):232.CrossRefGoogle ScholarPubMed

Hezelgrave, N, and Shennan, A. Threatened and actual preterm labor. In: James, D, Steer, P, Weiner, C, , B G, Sc, R, (Eds.), High-Risk Pregnancy Management Options. 2. Fifth Ed, 2017; 1624–1647. Cambridge: Cambridge University Press.Google Scholar

Stock, SJ, Wotherspoon, LM, Boyd, KA, et al. Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: Individual participant data meta-analysis and health economic analysis. BMJ Open. 2018, 8(4):e020796.Google Scholar

Barros, FC, Papageorghiou, AT, Victora, CG, et al. The distribution of clinical phenotypes of preterm birth syndrome: Implications for prevention. JAMA Pediatrics. 2015, 169(3):220–229.Google Scholar

Rood, KM, and Buhimschi, CS. Genetics, hormonal influences, and preterm birth. Seminars in Perinatology. 2017, 41(7):401–408.Google Scholar

Villar, J, Papageorghiou, AT, Knight, HE, et al. The preterm birth syndrome: A prototype phenotypic classification. Am Journal of Obstetrics and Gynecology. 2012, 206(2):119–123.Google Scholar

Cobo, T, Kacerovsky, M, and Jacobsson, B. Risk factors for spontaneous preterm delivery. International Journal of Gynecology & Obstetrics. 2020, 150(1):17–23.Google Scholar

Goodfellow, L, Care, A, and Alfirevic, Z. Controversies in the prevention of spontaneous preterm birth in asymptomatic women: an evidence summary and expert opinion. BJOG: An International Journal of Obstetrics & Gynecology. 2020.Google Scholar

Torloni, MR, Betrán, AP, Daher, S, et al. Maternal BMI and preterm birth: A systematic review of the literature with meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine. 2009. 22(11):957–970.Google Scholar

Hobel, C, and Culhane, J. Role of psychosocial and nutritional stress on poor pregnancy outcome. Journal of Nutrition. 2003, 133(5 Suppl 2):1709s–1717s.Google Scholar

Williams, C, Fong, R, Murray, S, et al. Caesarean birth and risk of subsequent preterm birth: A retrospective cohort study. BJOG: An International Journal of Obstetrics & Gynecology. 2020.Google Scholar

Murray, SR, Stock, SJ, Cowan, S, et al. Spontaneous preterm birth prevention in multiple pregnancy. The Obstetrician & Gynaecologist. 2018, 20(1):57–63.Google Scholar

Goldenberg, RL, Hauth, JC, and Andrews, WW. Intrauterine infection and preterm delivery. New England Journal of Medicine. 2000, 342(20):1500–1507.Google Scholar

Chang, E. Preterm birth and the role of neuroprotection. BMJ: British Medical Journal. 2015, 350:g6661.Google Scholar

Gravett, MG, Witkin, SS, Haluska, GJ, et al. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. American Journal of Obstetrics and Gynecology. 1994, 171(6):1660–1667.Google Scholar

Saigal, S, and Doyle, LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. The Lancet. 2008, 371(9608):261–269.Google Scholar

Crump, C, Sundquist, J, and Sundquist, K. Preterm delivery and long term mortality in women: National cohort and co-sibling study. BMJ. 2020, 370:m2533.Google Scholar

Shynlova, O, Nadeem, L, Zhang, J, et al. Myometrial activation: Novel concepts underlying labor. Placenta. 2020, 92:28–36.Google Scholar

Smith, R, Smith, JI, Shen, X, et al. Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. The Journal of Clinical Endocrinology and Metabolism. 2009, 94(6):2066–2074.Google Scholar

Singh, S, Daga, MK, Kumar, A, et al. Role of oestrogen and its receptors in HEV‐associated feto‐maternal outcomes. Liver International. 2019, 39(4):633–639.Google Scholar

Menon, R, Bonney, EA, Condon, J, et al. Novel concepts on pregnancy clocks and alarms: Redundancy and synergy in human parturition. Human Reproduction Update. 2016, 22(5):535–560.Google Scholar

Mendelson, CR, Gao, L, and Montalbano, AP. Multifactorial regulation of myometrial contractility during pregnancy and parturition. Frontiers in Endocrinology. 2019, 10(714): 1–17.Google Scholar

Welsh, T, Johnson, M, Yi, L, et al. Estrogen receptor (ER) expression and function in the pregnant human myometrium: estradiol via ERα activates ERK1/2 signaling in term myometrium. Journal of Endocrinology. 2012, 212(2):227–238.Google Scholar

Makieva, S, Saunders, PTK, and Norman, JE. Androgens in pregnancy: Roles in parturition. Human Reproduction Update. 2014, 20(4):542–559.Google Scholar

Meakin, AS, and Clifton, VL. Review: Understanding the role of androgens and placental AR variants: Insight into steroid-dependent fetal-placental growth and development. Placenta. 2019, 84:63–68.Google Scholar

Carlsen, SM, Jacobsen, G, and Romundstad, P. Maternal testosterone levels during pregnancy are associated with offspring size at birth. European Journal of Endocrinology. 2006, 155(2):365–370.Google Scholar

He, X, Wang, P, Wang, Z, et al. Thyroid antibodies and risk of preterm delivery: A meta-analysis of prospective cohort studies. European Journal of Endocrinology. 2012, 167(4):455–464.Google Scholar

Thangaratinam, S, Tan, A, Knox, E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: Meta-analysis of evidence. BMJ. 2011, 342:d2616.Google Scholar

Korevaar, TIM, Derakhshan, A, Taylor, PN, et al. Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: A systematic review and meta-analysis. JAMA: The Journal of the American Medical Association. 2019, 322(7):632–641.Google Scholar

Rao, M, Zeng, Z, Zhou, F, et al. Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: A systematic review and meta-analysis. Human Reproduction Update. 2019, 25(3):344–361.Google Scholar

Chen, Y, Holzman, C, Chung, H, et al. Levels of maternal serum corticotropin-releasing hormone (CRH) at midpregnancy in relation to maternal characteristics. Psychoneuroendocrinology. 2010, 35(6):820–832.Google Scholar

You, X, Liu, J, Xu, C, et al. Corticotropin-Releasing Hormone (CRH) promotes inflammation in human pregnant myometrium: The evidence of CRH initiating parturition? The Journal of Clinical Endocrinology and Metabolism. 2014, 99(2):E199–E208.Google Scholar

Shynlova, O, Lee, Y-H, Srikhajon, K, et al. Physiologic uterine inflammation and labor onset: Integration of endocrine and mechanical signals. Reproductive Sciences. 2013, 20(2):154–167.Google Scholar

Menon, R, Behnia, F, Polettini, J, et al. Placental membrane aging and HMGB1 signaling associated with human parturition. Aging. 2016, 8(2):216–230.Google Scholar

Padron, JG, Saito Reis, CA, and Kendal-Wright, CE. The role of danger associated molecular patterns in human fetal membrane weakening. Frontiers in Physiology. 2020, 11(602): 1–18.Google Scholar

Romero, R, Espinoza, J, Gonçalves, LF, et al. Inflammation in preterm and term labour and delivery. Seminars in Fetal and Neonatal Medicine. 2006, 11(5):317–326.Google Scholar

Berghella, V, and Saccone, G. Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Library: Cochrane Reviews. 2019, 9(9):Cd007235.Google Scholar

Iams, JD, Romero, R, Culhane, JF, et al. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. The Lancet. 2008, 371(9607):164–175.Google Scholar

National Collaborating Centre for Ws, Children’s H. National Institute for Health and Care Excellence: Clinical Guidelines. Preterm Labour and Birth. London: National Institute for Health and Care Excellence (UK) National Collaborating Centre for Women’s and Children’s Health; 2015.Google Scholar

Owen, J, Yost, N, Berghella, V, et al. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA. 2001, 286(11):1340–1348.Google Scholar

Berghella, V, and Saccone, G. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database of Systematic Reviews. 2019, 7.Google Scholar

Excellence NIfHaC. Biomarker Tests to Help Diagnose Preterm Labour in Women with Intact Membranes. London: NICE; 2018.Google Scholar

Heng, Y, Pennell, C, Chua, HN, et al. Whole blood gene expression profile associated with spontaneous preterm birth in women with threatened preterm labor. PLoS ONE. 2014, 9:e96901.Google Scholar

Heng, YJ, Pennell, CE, McDonald, SW, et al. Maternal whole blood gene expression at 18 and 28 weeks of gestation associated with spontaneous preterm birth in asymptomatic women. PLoS ONE. 2016, 11(6):e0155191.Google Scholar

Gibb, D, and Saridogan, E. The role of transabdominal cervical cerclage techniques in maternity care. The Obstetrician & Gynaecologist. 2016, 18(2):117–125.Google Scholar

Dodd, JM, Jones, L, Flenady, V, et al. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database of Systematic Reviews. 2013, (7):CD004947.Google Scholar

Norman, JE, Marlow, N, Messow, C-M, et al. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): A multicentre, randomised, double-blind trial. The Lancet. 2016, 387(10033):2106–2116.Google Scholar

Berghella, V, Odibo, AO, To, MS, et al. Cerclage for short cervix on ultrasonography: Meta-Analysis of trials using individual patient-level data. Obstetrics & Gynecology. 2005, 106(1).Google Scholar

Ehsanipoor, RM, Seligman, NS, Saccone, G, et al. Physical examination-indicated cerclage: A systematic review and meta-analysis. Obstet Gynecol. 2015, 126(1):125–135.Google Scholar

Hermans, FJR, Schuit, E, Bekker, MN, et al. Cervical pessary after arrested preterm labor: A randomized controlled trial. Obstetrics & Gynecology. 2018, 132(3).Google Scholar

Haas, DM, Caldwell, DM, Kirkpatrick, P, et al. Tocolytic therapy for preterm delivery: Systematic review and network meta-analysis. BMJ: British Medical Journal. 2012, 345:e6226.Google Scholar

Caritis, S. Adverse effects of tocolytic therapy. BJOG: An International Journal of Obstetrics & Gynaecology. 2005, 112(s1):74–78.Google Scholar

McGoldrick, E, Stewart, F, Parker, R, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews. 2020, 12(12):CD004454.Google Scholar

ACOG. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstetrics and Gynecology. 2017, 130(5):1159.Google Scholar

Doyle, LW, Crowther, CA, Middleton, P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews. 2009, (1):CD004661.Google Scholar

Elovitz, MA, and Mrinalini, C. Animal models of preterm birth. Trends in Endocrinology and Metabolism. 2004, 15(10):479–487.Google Scholar

Faro, J, Romero, R, Schwenkel, G, et al. Intra-amniotic inflammation induces preterm birth by activating the NLRP3 inflammasome. Biology of Reproduction. 2019, 100(5):1290–1305.Google Scholar

Coleman, M, Orvis, A, Wu, T-Y, et al. A broad spectrum chemokine inhibitor prevents preterm labor but not microbial invasion of the amniotic cavity or neonatal morbidity in a non-human primate model. Frontiers in Immunology. 2020, 11(770).Google Scholar

Shynlova, O, and Lye, SJ. Regulation of parturition. In: Croy, BA, Yamada, AT, DeMayo, FJ, Adamson, SL (Eds), The Guide to Investigation of Mouse Pregnancy. 2014; 373–389. Boston: Academic Press.Google Scholar

Bryan, FM, and Michael, JT. Are animal models relevant to key aspects of human parturition? American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2009, 297(3):525–545.Google Scholar

Dinny Graham, J, and Clarke, CL. Physiological action of progesterone in target tissues. Endocrine Reviews. 1997, 18(4):502–519.Google Scholar

Holt, R, Timmons, BC, Akgul, Y, et al. The molecular mechanisms of cervical ripening differ between term and preterm birth. Endocrinology. 2011, 152(3):1036–1046.Google Scholar

Motomura, K, Romero, R, Garcia-Flores, V, et al. The alarmin interleukin-1α causes preterm birth through the NLRP3 inflammasome. Molecular Human Reproduction. 2020, 26(9):712–726.Google Scholar

Hirsch, E, and Wang, H. The molecular pathophysiology of bacterially induced preterm labor: Insights from the murine model. The Journal of the Society for Gynecologic Investigation: JSGI. 2005, 12(3):145–155.Google Scholar

MacIntyre, DA, Sykes, L, Teoh, TG, et al. Prevention of preterm labour via the modulation of inflammatory pathways. The Journal of Maternal-Fetal & Neonatal Medicine. 2012, 25(Suppl 1):17–20.Google Scholar

Mulligan, MS, and Ward, PA. Immune complex-induced lung and dermal vascular injury. Differing requirements for tumor necrosis factor-alpha and IL-1. The Journal of Immunology. 1992, 149(1):331–339.Google Scholar

Elovitz, MA, Brown, AG, Breen, K, et al. Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury. International Journal of Developmental Neuroscience. 2011, 29(6):663–671.Google Scholar

Gross, GA, Imamura, T, Luedke, C, et al. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proceedings of the National Academy of Sciences (PNAS). 1998, 95(20):11875–11879.Google Scholar

Wang, H, Xie, H, and Dey, SK. Loss of cannabinoid receptor CB1 induces preterm birth. PLoS ONE. 2008, 3(10):1–8.Google Scholar

Hirsch, E, Filipovich, Y, and Mahendroo, M. Signaling via the type I IL-1 and TNF receptors is necessary for bacterially induced preterm labor in a murine model. American Journal of Obstetrics and Gynecology. 2006, 194(5):1334–1340.Google Scholar

Gonzalez, JM, Romero, R, and Girardi, G. Comparison of the mechanisms responsible for cervical remodeling in preterm and term labor. Journal of Reproductive Immunology. 2012, 97(1):112–119.Google Scholar

Soloff, MS, Jeng, Y-J, Izban, MG, et al. Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reproductive Sciences. 2011, 18(8):781–797.Google Scholar

Shynlova, O, Nadeem, L, Dorogin, A, et al. The selective progesterone receptor modulator, Promegestone, delays term parturition and prevents infection-mediated preterm birth in mice. AJOG. 2022, 226(2):249.e1–249.e21.Google Scholar

Shynlova, O, Dorogin, A, Li, Y, et al. Inhibition of infection-mediated preterm birth by administration of broad spectrum chemokine inhibitor in mice. Journal of Cellular and Molecular Medicine. 2014, 18(9):1816–1829.Google Scholar

Stock, SJ, Thomson, AJ, Papworth, S; the Royal College of Obstetricians, Gynaecologists. Antenatal corticosteroids to reduce neonatal morbidity and mortality. BJOG: An International Journal of Obstetrics & Gynecology. 2022.Google Scholar

Moleti, M, Trimarchi, F, and Vermiglio, F. Thyroid physiology in pregnancy. Endocr Pract. 2014, 6: 589–596.Google Scholar

Taylor, PN, Albrecht, D, Scholz, A, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018, 14: 301–316.Google Scholar

Garmendia Madariaga, A, Santos Palacios, S, Guillén-Grima, F, et al. The incidence and prevalence of thyroid dysfunction in Europe. J Clin Endocrinol Metab. 2014, 99: 923–931.Google Scholar

Carlé, A, Andersen, SL, Boelaert, K, et al. Subclinical thyrotoxicosis: Prevalence, causes and choice of therapy. Eur J Endocrinol. 2017, 176: R325–37.Google Scholar

Bartalena, L. Diagnosis and management of Graves’ disease: A global overview. Nat Rev Endocrinol. 2013, 9: 724–734.Google Scholar

Carlé, A, Bulow Pedersen, I, Knudsen, N, et al. Epidemiology of subtypes of hyperthyroidism in Denmark: A population-based study. Eur J Endocrinol. 2011, 164: 801–809.Google Scholar

Cooper, DS, and Laurberg, P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013, 1: 238–249.Google Scholar

Kahaly, GJ. Management of Graves thyroidal and extrathyroidal disease: An update. J Clin Endocrinol Metab. 2020, 105: 3704–3720.Google Scholar

Abraham-Nordling, M, Bystrom, K, Torring, O, et al. Incidence of hyperthyroidism in Sweden. Eur J Endocrinol. 2011, 165: 899–905.Google Scholar

Korelitz, JJ, McNally, DN, Masters, MN, et al. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid. 2013, 23: 758–765.Google Scholar

Korevaar, TIM, Medici, M, Visser, TJ, et al. Thyroid disease in pregnancy: new insights in diagnosis and clinical management. Nat Rev Endocrinol. 2017, 13: 610–622.Google Scholar

Rodien, P, Bremont, C, Sanson, ML, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med. 1998, 339: 1823–1826.Google Scholar

Lee, RH, Spencer, CA Mestman, JH, et al. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol. 2009; 200: 260. e1–6.Google Scholar

Bartalena, L, and Fatourechi, V. Extrathyroidal manifestations of Graves’ disease: a 2014 update. J Endocrinol Invest. 2014, 37: 691–700.Google Scholar

Yoshihara, A, Noh, JY, Mukasa, K, et al. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves’ disease and GTT? Endocr J. 2015, 62: 557–560.Google Scholar

Alexander, EK, Pearce, EN, Brent, GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and post-partum. Thyroid. 2017, 27: 315–389.Google Scholar

Medici, M, Timmermans, M, Visser, W, et al. Maternal thyroid hormone parameters during early pregnancy and birth weight: the Generation R Study. J Clin Endocrinol Metab. 2013, 98: 59–66.Google Scholar

Korevaar, TIM, Muetzel, R, Medici, M, et al. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol. 2016, 4: 35–43.Google Scholar

Mannisto, T, Mendola, P, Grewal, J, et al. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab. 2013, 98: 2725–2733.Google Scholar

Andersen, SL, Laurberg, P, Wu, CS, et al. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid disorders: A Danish nationwide cohort study. BJOG. 2014, 121: 1365–1374.Google Scholar

Andersen, SL, Olsen, J, Wu, CS, et al. Spontaneous abortion, stillbirth and hyperthyroidism: A Danish population-based study. Eur Thyroid J. 2014, 3: 164–172.Google Scholar

Andersen, Sl, Olsen, J, and Laurberg, P. Foetal programming by maternal thyroid disease. Clin Endocrinol (Oxf). 2015, 83: 751–758.Google Scholar

Kahaly, GJ, Bartalena, L, Hegedus, L, et al. 2018 European Thyroid Association guideline for the management of Graves’ hyperthyroidism. Eur Thyroid J. 2018, 7: 167–186.Google Scholar

Bartalena, L, Chiovato, L, and Vitti, P. Management of hyperthyroidism due to Graves’ disease: Frequently asked questions and answers (if any). J Endocrinol Invest. 2016, 39: 1105–1114.Google Scholar

Andersen, SL, Olsen, J, and Laurberg, P. Antithyroid drug side effects in the population and in pregnancy. J Clin Endocrinol Metab. 2016, 101: 1606–1614.Google Scholar

Andersen, SL, Olsen, J, Wu, CS, et al. Birth defects after early pregnancy use of antithyroid drugs: A Danish nationwide study. J Clin Endocrinol Metab. 2013, 98: 4373–4381.Google Scholar

Tonacchera, M, Chiovato, L, Bartalena, L, et al. Treatment of Graves’ disease with thionamides: A position paper on indications and safety in pregnancy. J Endocrinol Invest. 2020, 43: 257–265.Google Scholar

Rotondi, M, Cappelli, C, Pirali, B, et al. The effect of pregnancy on subsequent relapse from Graves’ disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab. 2008, 93: 3985–3988.Google Scholar

Shan, Z, and Teng, W. Thyroid hormone therapy of hypothyroidism in pregnancy. Endocrine. 2019, 66: 35–42.Google Scholar

Teng, W, Shan, Z, Patil-Sisodia, K, et al. Hypothyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013, 1: 228–237.Google Scholar

Zimmermann, MB, Burgi, H, and Hurrell, R. Iron deficiency predicts poor maternal thyroid status during pregnancy. J Clin Endocrinol Metab. 2007, 92: 3436–3440.Google Scholar

Lazarus, JH, Brown, RS, Daumerie, C, et al. 2014 European Thyroid Association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014, 3: 76–94.Google Scholar

Stagnaro-Green, A, Abalovich, M, Alexander, E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011, 21: 1081–1125.Google Scholar

Haddow, JE, Palomaki, GE, Allan, WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999, 341: 549–555.Google Scholar

Ge, GM, Leung, MTY, Man, KKC, et al. Maternal thyroid dysfunction during pregnancy and the risk of adverse outcomes in the offspring: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2020, 105(12): dgaa555. https://doi.org/10.1210/clinem/dgaa555.Google Scholar

Maraka, S, Singh Ospina, NM, O’Keefe, DT, et al. Subclinical hypothyroidism in pregnancy: A systematic review and meta-analysis. Thyroid. 2016, 26: 580–590.Google Scholar

Derakhshan, A, Peeters, RP, Taylor, PN, et al. Association of maternal thyroid function with birthweight: A systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol. 2020, 8: 501–510.Google Scholar

Rotondi, M, Chiovato, L, Pacini, F, et al. Management of subclinical hypothyroidism in pregnancy: A comment from the Italian Society of Endocrinology and the Italian Thyroid Association to the 2017 American Thyroid Association guidelines- “The Italian way”. Thyroid. 2018, 551–555.Google Scholar

Lazarus, JH, Bestwick, JP, Channon, S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012, 366: 493–501.Google Scholar

Casey, BM, Thom, EA, Peaceman, AM, et al. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med. 2017, 376: 815–825.Google Scholar

Taylor, PN, Muller, I, Nana, M, et al. Indications for treatment of subclinical hypothyroidism and isolated hypothyroxinemia in pregnancy. Best Pract Res Clin Endocrinol Metab. 2020. https://doi.org/10.1016/j.beem.2020.101436.Google Scholar

Stagnaro-Green, A, Dong, A, and Stephenson, MD. Universal screening for thyroid disease during pregnancy should be performed. Best Pract Res Clin Endocrinol Metab. 2019. https://doi.org/10.1016/j.beem.2019.101320.Google Scholar

Hollowell, JG, Staehling, NW, Flanders, WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002, 87: 489–499.Google Scholar

De Leo, S, and Pearce, EN. Autoimmune thyroid disease during pregnancy. Lancet Diabetes Endocrinol. 2018, 6: 575–586.Google Scholar

Lau, L, Benham, JL, Lemieux, P, et al. Impact of levothyroxine in women with thyroid antibodies on pregnancy outcomes: A systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2021, 11(2): e043751. https://doi.org/10.1136/bmjopen-2020-043751.Google Scholar

van den Boogard, E, Vissenberg, R, Landa, JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: A systematic review. Hum Reprod Update. 2011, 17: 605–619.Google Scholar

Busnelli, A, Paffoni, A, Fedele, L, and et al. The impact of thyroid autoimmunity on IVF/ICSI outcome: A systematic review and meta-analysis. Hum Reprod Update. 2016, 22: 793–794.Google Scholar

Poppe, K, Bisschop, P, Fugazzola, L, et al. 2021 European Thyroid Association guideline on thyroid disorders prior to and during assisted reproduction. Eur Thyroid J. 2020; 9: 281–295.Google Scholar

Stagnaro-Green, A, Schwartz, A, Gismondi, R, et al. High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in Southern Italy. J Clin Endocrinol Metab. 2011; 96: 652–657.Google Scholar

Stagnaro-Green, A. Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab. 2012, 97: 334–342.Google Scholar

Staff, AC, Redman, CW, Williams, D, et al. Pregnancy and long-term maternal cardiovascular health: Progress through harmonization of research cohorts and biobanks. Hypertension. 2016, 67:251–260.Google Scholar

Stojanovska, V, Scherjon, SA, and Plosch, T. Preeclampsia as modulator of offspring health. Biol Reprod. 2016, 94:53.Google Scholar

Piering, WF, Garancis, JG, Becker, CG, et al. Preeclampsia related to a functioning extrauterine placenta: Report of a case and 25-year follow-up. Am J Kidney Dis. 1993, 21:310–313.Google Scholar

Brittain, PC, and Bayliss, P. Partial hydatidiform molar pregnancy presenting with severe preeclampsia prior to twenty weeks gestation: A case report and review of the literature. Mil Med. 1995, 160:42–44.Google Scholar

Chesley, LC. Hypertensive disorders of pregnancy. In. New York: Appleton-Century-Crofts, 1978.Google Scholar

Roberts, JM, Taylor, RN, Musci, TJ, et al. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol. 1989, 161:1200–1204.Google Scholar

Redman, CW, Sacks, GP, and Sargent, IL. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999, 180:499–506.Google Scholar

Redman, CWG, Staff, AC, and Roberts, JM. Syncytiotrophoblast stress in preeclampsia: The convergence point for multiple pathways. Am J Obstet Gynecol. 2020, 08:08.Google Scholar

Salas, SP, Marshall, G, Gutierrez, BL, et al. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension. 2006, 47:203–208.Google Scholar

Duvekot, JJ, Cheriex, EC, Pieters, FA, et al. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol. 1993, 169:1382–1392.Google Scholar

Oelkers, WK. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids. 1996, 61:166–171.Google Scholar

Van Buren, GA, Yang, DS, and Clark, KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol. 1992, 167:828–833.Google Scholar

Johnson, ML, Grazul-Bilska, AT, Redmer, DA, et al. Effects of estradiol-17beta on expression of mRNA for seven angiogenic factors and their receptors in the endometrium of ovariectomized (OVX) ewes. Endocrine. 2006, 30:333–342.Google Scholar

Miller, VM, and Vanhoutte, PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 1991, 261:R1022–1027.Google Scholar